Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCARVALHO, Joao Paulo Mancusi de
dc.contributor.authorSALIM, Rafael C.
dc.contributor.authorCARVALHO, Filomena Marino
dc.contributor.authorGENTA, Maria Luiza Nogueira Dias
dc.contributor.authorBARACAT, Edmund Chada
dc.contributor.authorCARVALHO, Jesus Paula
dc.identifier.citationJOURNAL OF CLINICAL PATHOLOGY, v.73, n.11, p.748-753, 2020
dc.description.abstractAims L1 cell adhesion molecule (L1CAM) has been shown to be correlated with tumour progression, attributed to its possible association with epithelial-mesenchymal transition (EMT), characterised by the expression of vimentin and loss of e-cadherin. Herein, we investigate the associations between L1CAM and clinicopathological parameters, as well as the expression of vimentin and e-cadherin, in carcinomas restricted to the cervix. Methods The study was retrospective observational and included 45 squamous cell carcinomas (63.4%) and 26 adenocarcinomas (36.6%) submitted to primary surgical treatment. Patient age, FIGO (International Federation of Gynecology and Obstetrics) stage, tumour size and follow-up were obtained from the medical records. All the slides were revised to evaluate histological differentiation, lymphovascular space invasion, depth of infiltration, disease-free cervical wall thickness, pattern of invasion front, Silva pattern (for adenocarcinomas) and the percentage of tumour-infiltrating lymphocytes. Tissue microarrays were constructed for immunohistochemical staining for L1CAM, e-cadherin and vimentin. Results Adenocarcinomas were associated with lower disease-free and overall survival. L1CAM and vimentin expressions were more frequent among adenocarcinomas, although loss of e-cadherin expression was more common among squamous carcinomas. L1CAM expression was associated with larger tumours, vimentin expression and lower disease-free survival. No association was observed between the expression of either L1CAM or vimentin and loss of e-cadherin. High levels of tumour-infiltrating lymphocytes were more frequent in squamous cell carcinoma, high-grade tumours, destructive pattern at front of invasion and loss of e-cadherin expression. Conclusions Our results confirm the prognostic role of L1CAM in cervical carcinomas, but suggest a role for mechanisms other than EMT.eng
dc.relation.ispartofJournal of Clinical Pathology
dc.subjectcervix uterieng
dc.subjectuterine cervical neoplasmseng
dc.titleL1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomaseng
dc.rights.holderCopyright BMJ PUBLISHING GROUPeng
dc.type.categoryoriginal articleeng
hcfmusp.relation.referenceBanister CE, 2017, ONCOTARGET, V8, P13375, DOI 10.18632/oncotarget.14533eng
hcfmusp.relation.referenceBhatla N, 2019, INT J GYNECOL OBSTET, V145, P129, DOI 10.1002/ijgo.12749eng
hcfmusp.relation.referenceBurk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386eng
hcfmusp.relation.referenceChen JL, 2018, EXP THER MED, V15, P2792, DOI 10.3892/etm.2018.5747eng
hcfmusp.relation.referenceChen T, 2017, J CELL PHYSIOL, V232, P3261, DOI 10.1002/jcp.25797eng
hcfmusp.relation.referenceCheng Y, 2012, HUM PATHOL, V43, P1213, DOI 10.1016/j.humpath.2011.08.025eng
hcfmusp.relation.referenceDe Vivar AD, 2013, INT J GYNECOL PATHOL, V32, P592, DOI 10.1097/PGP.0b013e31829952c6eng
hcfmusp.relation.referenceEstimativa, 2018, INC CANC BRASeng
hcfmusp.relation.referenceGLOBOCAN, 2018, INC MORT PREV CANC Seng
hcfmusp.relation.referenceGrage-Griebenow E, 2014, MOL ONCOL, V8, P982, DOI 10.1016/j.molonc.2014.03.001eng
hcfmusp.relation.referenceHuszar M, 2010, J PATHOL, V220, P551, DOI 10.1002/path.2673eng
hcfmusp.relation.referenceIchikawa T, 2019, BRIT J CANCER, V121, P1058, DOI 10.1038/s41416-019-0646-8eng
hcfmusp.relation.referenceJiang J, 2019, ONCOL LETT, V17, P5729, DOI 10.3892/ol.2019.10266eng
hcfmusp.relation.referenceKiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832eng
hcfmusp.relation.referenceKlat J, 2019, ANTICANCER RES, V39, P421, DOI 10.21873/anticanres.13128eng
hcfmusp.relation.referenceKurman RJ CM, 2014, WHO CLASSIFICATION Teng
hcfmusp.relation.referenceLiu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160eng
hcfmusp.relation.referenceLu W, 2019, DEV CELL, V49, P361, DOI 10.1016/j.devcel.2019.04.010eng
hcfmusp.relation.referencePeng JF, 2016, FUTURE ONCOL, V12, P715, DOI 10.2217/fon.15.332eng
hcfmusp.relation.referenceSalgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450eng
hcfmusp.relation.referenceSchrevel M, 2017, ONCOTARGET, V8, P87568, DOI 10.18632/oncotarget.20976eng
hcfmusp.relation.referenceSedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387eng
hcfmusp.relation.referenceShtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106eng
hcfmusp.relation.referenceStewart CJR, 2011, HISTOPATHOLOGY, V58, P720, DOI 10.1111/j.1365-2559.2011.03787.xeng
hcfmusp.relation.referenceStolnicu S, 2018, AM J SURG PATHOL, V42, P214, DOI 10.1097/PAS.0000000000000986eng
hcfmusp.relation.referenceTampakis A, 2020, ACTA ONCOL, V59, P55, DOI 10.1080/0284186X.2019.1667022eng
hcfmusp.relation.referenceTischler V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-127eng
hcfmusp.relation.referencevan der Maten M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174180eng
hcfmusp.relation.referenceVersluis MAC, 2018, VIRCHOWS ARCH, V473, P591, DOI 10.1007/s00428-018-2444-8eng
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MOG
Departamento de Obstetrícia e Ginecologia - FM/MOG

Artigos e Materiais de Revistas Científicas - FM/MPT
Departamento de Patologia - FM/MPT

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/14
LIM/14 - Laboratório de Investigação em Patologia Hepática

Artigos e Materiais de Revistas Científicas - LIM/58
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)451.58 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.